Biosight
Innovative therapeutics for safer, more effective cancer treatment, improving patient outcomes and quality of life. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
AUD167—250m (Dealroom.co estimates Dec 2020.)
Company register number 512852559
Lod Center District (HQ)
Authorizing premium user...